Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Fabry disease and the heart: a comprehensive review
O Azevedo, F Cordeiro, MF Gago… - International journal of …, 2021 - mdpi.com
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations of the
GLA gene that result in a deficiency of the enzymatic activity of α-galactosidase A and …
GLA gene that result in a deficiency of the enzymatic activity of α-galactosidase A and …
T1 map** in cardiac MRI
Quantitative myocardial and blood T 1 have recently achieved clinical utility in numerous
pathologies, as they provide non-invasive tissue characterization with the potential to …
pathologies, as they provide non-invasive tissue characterization with the potential to …
An expert consensus document on the management of cardiovascular manifestations of Fabry disease
Fabry disease (FD) is an X‐linked lysosomal storage disorder caused by pathogenic
variants in the α‐galactosidase A (GLA) gene that leads to reduced or undetectable α …
variants in the α‐galactosidase A (GLA) gene that leads to reduced or undetectable α …
Fabry disease in cardiology practice: literature review and expert point of view
Fabry disease is an X-linked progressive multisystemic genetic sphingolipidosis caused by
deficient activity of lysosomal α-galactosidase A. Men aged> 30 years and women aged> 40 …
deficient activity of lysosomal α-galactosidase A. Men aged> 30 years and women aged> 40 …
Update on hypertrophic cardiomyopathy and a guide to the guidelines
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder,
affecting 1 in 500 individuals worldwide. Existing epidemiological studies might have …
affecting 1 in 500 individuals worldwide. Existing epidemiological studies might have …
The role of cardiac imaging in the diagnosis and management of Anderson-Fabry disease
Anderson-Fabry disease (AFD) is a rare X-linked inherited metabolic disorder which results
in a deficiency or absence of the enzyme α-galactosidase A, leading to the accumulation of …
in a deficiency or absence of the enzyme α-galactosidase A, leading to the accumulation of …
Myocardial edema, myocyte injury, and disease severity in Fabry disease
JB Augusto, S Nordin, R Vijapurapu… - Circulation …, 2020 - ahajournals.org
Background: Cardiovascular magnetic resonance can demonstrate myocardial processes in
Fabry disease (FD), such as low native T1 (sphingolipid storage) and late gadolinium …
Fabry disease (FD), such as low native T1 (sphingolipid storage) and late gadolinium …
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association …
B Moura, A Aimo, A Al‐Mohammad… - European Journal of …, 2023 - Wiley Online Library
Left ventricular (LV) hypertrophy consists in an increased LV wall thickness. LV hypertrophy
can be either secondary, in response to pressure or volume overload, or primary, ie not …
can be either secondary, in response to pressure or volume overload, or primary, ie not …
Cardiac phenotype of prehypertrophic Fabry disease
S Nordin, R Kozor, S Baig, A Abdel-Gadir… - Circulation …, 2018 - ahajournals.org
Background: Fabry disease (FD) is a rare and treatable X-linked lysosomal storage disorder.
Cardiac involvement determines outcomes; therefore, detecting early changes is important …
Cardiac involvement determines outcomes; therefore, detecting early changes is important …